Inventiva share price logo

Inventiva

NASDAQ: IVA

Small Cap

$3.71

+0.10

(+2.92%)

Live

as on

Inventiva Stock Performance

as on October 24, 2026 at 6:28 am IST

  • Day's Low

    Day's High

    $3.47
    $3.73
    downward going graph

    6.47%

    Downside

    0.54%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.82
    $7.98
    downward going graph

    23.99%

    Downside

    115.16%

    Upside

    downward going graph

Inventiva share price movements today

Previous Close
$3.60
Open
$3.53
Volume
4.1M
Market Cap
$838.6M
Day's Low - High
$3.47 - $3.73
52 Week Low - High
$2.82 - $7.98

Inventiva Historical Returns

1 Month Return
+ 4.35 %
3 Month Return
-20.18 %
1 Year Return
-38.67 %
3 Year Return
-5.26 %
5 Year Return
-74.72 %

Inventiva Stock Fundamentals & Key Indicators

Check Inventiva market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$838.6M

EPS (TTM)

-0.54

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.88

Industry PE ratio

-9.93

PEG Ratio

-0.04

EBITDA

-148.4M

Revenue (TTM)

1.3M

Profit Margin

-5232.65%

Return On Equity TTM

-1625.48%

Inventiva vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Inventiva with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Inventiva image
Inventiva
StrongBuy$838.6M-74.72%-5.88-5232.65%0.00%
Moderna image
Moderna
Neutral$98.1B-37.95%-30.80-12.57%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$44.0BNA27.4787.82%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.9B191.61%30.2886.04%0.00%
Regeneron image
Regeneron
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Inventiva Stock including INR - Dollar returns

The Inventiva stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Inventiva investment value today

Current value as on today

₹68,359

Returns

-₹31,641

(-31.64%)

Returns from Inventiva Stock

-₹36,797 (-36.8%)

Dollar Impact

₹5,156 (+5.16%)

Analyst Recommendation on Inventiva Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Inventiva. Average target price of $15.2

Inventiva Share Price Target

Get share price movements and forecasts by analysts on Inventiva.

What analysts predicted

75.59%UPSIDE

Target Price

$15.2

Current Price

$3.71

Analyzed by

8 Analysts

High

$26

Target

$15.20

Low

$10

Inventiva target price $15.2, a slight upside of 75.59% compared to current price of $3.71. According to 8 analysts rating.

Indian Investors' Interest in Inventiva Stock

Search interest for Inventiva Stock has increased by 310% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:310% versus previous 30 day period

Inventiva Quarterly Profit & Loss

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Total Revenue
4
0
15
6
16
2
6
4
0
1
Gross Profit
3
0
14
6
15
2
6
2
-1
0
Operating Income
-30
-36
-23
-55
-47
-52
-45
-56
-74
-70
EBITDA
-28
-32
-22
-53
-46
-50
-117
-165
-77
-70
Interest Expense
0
0
0
1
3
5
12
9
23
14
Depreciation
0
0
1
1
1
1
1
1
1
1
Income Before Tax
-28
-32
-24
-55
-54
-48
-134
-177
-164
-69
Income Tax Expense
-2
-3
0
0
0
0
0
-1
0
0
Net Income
-26
-29
-24
-55
-55
-49
-135
-175
-176
-70
Net Profit Margin
86.24%
-677.61%
96.93%
93.07%
96.63%
80.76%
108.14%
61.74%
-4062.12%
64.90%

Inventiva Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
3
6
0
4
12
17
9
4
Gross Profit
5
2
6
4
4
17
17
9
1
Operating Income
-20
-33
-30
-29
-52
-57
-102
-97
-130
EBITDA
-21
-32
-28
-30
-
-55
-102
-166
-127
Interest Expense
0
0
0
0
0
0
5
12
32
Depreciation
1
0
1
1
-
1
2
5
3
Income Before Tax
-20
-33
-30
-33
-49
-54
-109
-183
-342
Income Tax Expense
-3
0
-
-
0
0
0
0
0
Net Income
-17
-33
-30
-33
-49
-54
-110
-184
-340
Net Profit Margin
81.05%
69.75%
100.00%
1187.37%
100.00%
140.05%
100.13%
100.00%
33.68%

Inventiva Quarterly Cash Flow

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Net Income
-26
-29
-24
-55
-55
-49
-135
-175
-176
-70
Operating Cash Flow
-27
-26
-18
-45
-36
-48
-37
-53
-54
-58
Investing Cash Flow
-6
0
9
-7
0
8
0
-24
-109
64
Financing Cash Flow
25
13
23
-2
31
22
123
104
142
61
Change in Cash
-7
-10
10
-55
-4
10
96
25
-22
63

Inventiva Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-33
-30
-33
-49
-54
-110
-184
-340
Operating Cash Flow
-17
-34
-28
-30
-47
-44
-81
-85
-100
Investing Cash Flow
6
0
0
-8
-1
8
-7
8
-127
Financing Cash Flow
45
32
8
111
25
37
29
145
232
Change in Cash
34
-2
-20
69
-19
0
-59
69
14

Global Institutional Holdings in Inventiva

Check out the Institutions with significant holdings in Inventiva.

Funds
Holdings
Michael Rockefeller
0.98%
Franklin Strategic Series
0.41%
Fidelity Advisor Series VII
0.29%
Simplify
0.13%
Artisan Partners Funds Inc.
0.08%
See all

Inventiva News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 11:01 AM

    -

    Inventiva seeks $125 million from a U.S. public offering of American Depositary Shares for clinical trials and commercialization activities.

    Thu, 01:10 PM

    -

    Inventiva announces temporary trading halt of ordinary shares on Euronext Paris due to the U.S. public offering.

    Thu, 08:17 PM

    -

    Inventiva sets terms for U.S. ADS offering, issuing 38,961,038 new shares at $3.85 each, aiming for $140.1 million.

  • img

    Today's Timeline - 13 November

    Thu, 08:55 PM

    -

    Inventiva announces trading resumption of ordinary shares on Euronext Paris after halt for U.S. offering.

Insights on Inventiva

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IVA stock has moved up by 22.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 163.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 710.6%

About Inventiva

Inventiva S.A. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of orally administered small molecule therapeutics. The firm primarily targets serious conditions such as non-alcoholic steatohepatitis (NASH), various forms of mucopolysaccharidoses (MPS), and other significant diseases. The company's most advanced experimental drug is Lanifibranor, which has successfully completed Phase IIb clinical trials for the treatment of NASH. Inventiva is also progressing with Odiparcil, an asset that has finished its Phase IIa clinical studies for addressing the MPS VI subtype disease. Beyond these lead candidates, Inventiva maintains a robust pipeline of earlier-stage research and development programs, notably in oncology and other therapeutic areas. The company has also established important strategic alliances, including a partnership with AbbVie focused on treatments for autoimmune diseases, and a collaboration with Boehringer Ingelheim International GmbH aimed at discovering novel therapies for idiopathic pulmonary fibrosis. Inventiva S.A. was established in 2011 and is headquartered in Daix, France.
OrganisationInventiva
Headquarters50 rue de Dijon, Daix, BF, 21121, FR
IndustryBiotechnology
CEOAndrew Obenshain

Key Management of Inventiva

Name

Title

Dr. Martine Zimmermann Pharm.D.

Executive VP of Regulatory Affairs & Quality Assurance and Head of Regulatory Affairs

Mr. Jason A. Campagna M.D., Ph.D.

President of Research & Development and Chief Medical Officer

Mr. Axel-Sven Malkomes

Chief Financial Officer

Mr. Christopher Benecchi M.B.A.

Chief Operating Officer

Mr. Andrew Obenshain

Chief Executive Officer

Dr. Pierre Broqua Ph.D.

Co-Founder

Mr. Jean Volatier

Executive VP Finance & Corporate Social Responsibility

FAQs

What is Inventiva share price today?

Inventiva share price today is $3.71 as on . Inventiva share today touched a day high of $3.73 and a low of $3.47.

What is the 52 week high and 52 week low for Inventiva share?

Inventiva share touched a 52 week high of $7.98 on and a 52 week low of $2.82 on . Inventiva stock price today i.e. is trending at $3.71,which is 53.52% down from its 52 week high and 31.56% up from its 52 week low.

What is Inventiva's market capitalisation today?

Inventiva market capitalisation is $0.00T as on .

How to invest in Inventiva Stock (IVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inventiva on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Inventiva Stock (IVA) from India?

Indian investors can start investing in Inventiva (IVA) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Inventiva stock (as per the Rupee-Dollar exchange rate as on ). Based on Inventiva share’s latest price of $3.71 as on October 24, 2026 at 12:58 am IST, you will get 2.6954 shares of Inventiva. Learn more about fractional shares .

What are the returns that Inventiva has given to Indian investors in the last 5 years?

Inventiva stock has given -74.72% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?